Regeneron Pharma (REGN) PT Raised to $800 at Baird
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $852.03 +3.42%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
Baird analyst Brian Skorney raised the price target on Regeneron Pharma (NASDAQ: REGN) to $800.00 (from $756.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
- Wedbush Downgrades Tscan Therapeutics Inc (TCRX) to Neutral
- MiniMed Group (MMED) PT Raised to $27 at StoneX on Conservative Revenue Guide
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
